Adaptive Biotechnologies (ADPT) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Adaptive Biotechnologies (ADPT) is Neutral.

The composite score behind that read is +0.06, weighing +0.36 of bullish evidence against -0.22 bearish.

Adaptive Biotechnologies last closed at $26.49, +1.53% on the session.

Against the IVW growth benchmark the position is +0.73% over the forecast window.

The read is built from 15 underlying insights — 3 bullish and 12 bearish.

Agreement across those insights is 80%.

Adaptive Biotechnologies has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Adaptive Biotechnologies in the 23rd percentile on return on equity, where 100 is best.

Adaptive Biotechnologies is classified under Health Care / Life Sciences Tools & Services, with a market capitalisation of $4.16B.

StockMap tracks Adaptive Biotechnologies as the 23rd largest of the 41 companies it covers in the Life Sciences Tools & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 37 Neutral, 2 Moderate Outperform and 2 Moderate Underperform.

On that composite Adaptive Biotechnologies ranks 21st of 41 in the group, against a group median of +0.06.